1. ScholarBank@NUS

Wee Joo Chng

rp04705

Collaboration Map View Statistics Email Alert RSS Feed

Profile

Full Name
Wee Joo Chng
Variants
Chng W.J
Chng, W.J.
Chng W.-J.
Wee Joo Chng
Chng, W.-J.
 
Main Affiliation
 
Faculty
 
Email
mdccwj@nus.edu.sg
 
Other emails
 

Publications

Refined By:
Date Issued:  [2000 TO 2021]

Results 101-105 of 105 (Search time: 0.003 seconds).

Issue DateTitleAuthor(s)
101Aug-2013Type II EATL (epitheliotropic intestinal T-cell lymphoma): A neoplasm of intra-epithelial T-cells with predominant CD8αα phenotypeTan, S.-Y. ; Chuang, S.-S.; Tang, T.; Tan, L.; Ko, Y.-H.; Chuah, K.-L.; Ng, S.-B. ; Chng, W.-J. ; Gatter, K.; Loong, F.; Liu, Y.-H.; Hosking, P.; Cheah, P.-L.; Teh, B.-T. ; Tay, K.; Koh, M.; Lim, S.-T. 
102Jul-2012Type II enteropathy-associated T-cell lymphoma: A multicenter analysis from the Asia Lymphoma Study GroupTse, E.; Gill, H.; Loong, F.; Kim, S.J.; Ng, S.-B. ; Tang, T.; Ko, Y.-H.; Chng, W.-J. ; Lim, S.-T. ; Kim, W.S.; Kwong, Y.-L.
103Jan-2014Unusual case of metachronous EBV-associated B-cell and NK/T-cell lymphoma mimicking polymyositis-diagnostic challenges and pitfallsChan, E.H.L.; Lu, S.-J.; Petersson, F.; Tan, K.-B. ; Chng, W.-J. ; Ng, S.-B. 
104Feb-2013VS-5584, a novel and highly selective PI3K/mTOR kinase inhibitor for the treatment of cancerHart, S.; Novotny-Diermayr, V.; Goh, K.C.; Williams, M.; Tan, Y.C.; Ong, L.C.; Cheong, A.; Ng, B.K.; Amalini, C.; Madan, B.; Nagaraj, H.; Jayaraman, R.; Pasha, K.M.; Ethirajulu, K.; Chng, W.J. ; Mustafa, N.; Goh, B.C. ; Benes, C.; McDermott, U.; Garnett, M.; Dymock, B.; Wood, J.M.
1052018X-linked inhibitor of apoptosis inhibition sensitizes acute myeloid leukemia cell response to TRAIL and chemotherapy through potentiated induction of proapoptotic machineryZhou, J. ; Lu, X.; Tan, T.Z. ; Chng, W.-J.